# FibroScan-Reproducibility and Repeatability Study

> **NCT06877026** · NA · COMPLETED · sponsor: **Echosens** · enrollment: 108 (actual)

## Conditions studied

- Non-Alcoholic Fatty Liver Disease
- Liver Disease; Alcohol-Related

## Interventions

- **DEVICE:** FibroScan
- **OTHER:** Liver Enzymes

## Key facts

- **NCT ID:** NCT06877026
- **Lead sponsor:** Echosens
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-07-16
- **Primary completion:** 2026-02-25
- **Final completion:** 2026-02-27
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06877026

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06877026, "FibroScan-Reproducibility and Repeatability Study". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT06877026. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*